menu search

Xilio therapeutics to host live virtual program spotlighting xtx301, a tumor-activated il-12

WALTHAM, Mass., Nov. 23, 2022 (GLOBE NEWSWIRE) — Xilio Therapeutics, Inc. (Nasdaq: XLO), a biotechnology company developing tumor-activated immuno-o...

November 23, 2022, 12:30 pm


Search within

Pages Search Results: